# 2025-04285: Clinical Firm Applies to Import Controlled Marijuana Extracts into U.S.

2025-04285, Importer of Controlled Substance Application: Fisher Clinical Services, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-03-17, effective 2025-04-16; PRIA reads it as touching household money (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04285
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04285
- Title: Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 12367
- Published: 2025-03-17
- Effective: 2025-04-16
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

Clinical Firm Applies to Import Controlled Marijuana Extracts into U.S.

## Summary

Fisher Clinical Services, Inc. wants to become an official importer of some controlled substances, including marijuana extracts and other drugs. People and companies involved with these substances can share their thoughts or ask for a hearing by April 16, 2025. This move could impact how these drugs are imported and regulated, so keep an eye on the deadline to have your say!

## Abstract

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Comment and Hearing Deadline—April 16, 2025: benefit, low. If you are a registered bulk manufacturer or an applicant, you may submit electronic comments or objections about Fisher Clinical Services, Inc.'s importer application on or before April 16, 2025, via https://www.regulations.gov. You may also file a written request for a hearing by April 16, 2025,…
- Import Authorization Limited to Clinical Trials Only: mixed, low. Fisher Clinical Services, Inc. applied (on September 13, 2024) to import these controlled substances: Marihuana Extract (code 7350, Schedule I), Marihuana (7360, I), Dimethyltryptamine (7435, I), Psilocybin (7437, I), Methylphenidate (1724, II), Levorphanol (9220, II), Noroxymorphone (9668, II), an…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2025-04285 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/17/2025-04285/importer-of-controlled-substance-application-fisher-clinical-services-inc)
- [2025-04285 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-17/pdf/2025-04285.pdf)

## Related
- [Previous: 2025-04284, Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC](https://policyrisk.com/federal-register/2025-04284)
- [Next: 2025-04286, National Institute on Deafness and Other Communication Disorders; Notice of Clo…](https://policyrisk.com/federal-register/2025-04286)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04285 (as of 2026-09-30).